Dr. Fahed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
110 N 29th St
Suite 101
Norfolk, NE 68701Phone+1 402-644-7550Fax+1 402-644-7551
Education & Training
- Tulane UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009
- University of Kansas (Wichita)Residency, Internal Medicine, 2003 - 2006
- Lebanese University School of MedicineClass of 2002
Certifications & Licensure
- NE State Medical License 2008 - 2026
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2015 Mar 30
- Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery Start of enrollment: 2015 Dec 11
Publications & Presentations
PubMed
- 1 citationsA Case of Recurrent Severe Hypocalcemia with Prolonged Hospitalization and Readmissions After Single Dose of Denosumab in Metastatic Prostate Cancer Patient.Ojbindra Kc, Punya Hari Dahal, Manisha Koirala, Chandra Sekhar Kothagundla, Enas Al Zaghal
Journal of Community Hospital Internal Medicine Perspectives. 2022-01-01 - 2 citationsThe impact of the affordable care act on breast cancer care in the USA: A multi-institutional analysis.Jessica A. Maxwell, Oleg Shats, Joshua Aldridge, Elizabeth Lyden, Amy Krie
The Breast Journal. 2019-09-01 - 2 citationsEvolving role of monoclonal antibodies in the treatment of chronic lymphocytic leukemiaMohamed A. Kharfan-Dabaja, Rabih Fahed, Mohamad A. Hussein, Edgardo S. Santos
Expert Opinion on Investigational Drugs. 2007-10-30
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: